Gallichan; Scott
Patent Applications and Registrations
Patent applications and USPTO patent grants for Gallichan; Scott.The latest application filed is for "immunogenic compositions".
- Gallichan; Scott - Toronto CA
- Gallichan; Scott - Burlington CA
- Gallichan; Scott - Campbellville N/A CA
- Gallichan; Scott - Burington CA
- Gallichan, Scott - San Diego CA
| Patent | Date |
|---|---|
| Immunogenic Compositions App 20170157233 - Gallichan; Scott ; et al. | 2017-06-08 |
| Immunogenic compositions and related methods Grant 9,649,372 - Harper , et al. May 16, 2 | 2017-05-16 |
| Immunogenic Compositions App 20160367655 - Gallichan; Scott ; et al. | 2016-12-22 |
| Immunogenic compositions Grant 9,327,021 - Gallichan , et al. May 3, 2 | 2016-05-03 |
| Methods For Assessing Immunogenicity App 20150316567 - Salha; Marie-Danielle ; et al. | 2015-11-05 |
| Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer Grant 8,946,174 - Berinstein , et al. February 3, 2 | 2015-02-03 |
| Monoclonal antibodies and uses thereof Grant 8,802,383 - Berinstein , et al. August 12, 2 | 2014-08-12 |
| Immunogenic Compositions App 20130344109 - Gallichan; Scott ; et al. | 2013-12-26 |
| Immunogenic Compositions App 20130183350 - Harper; Kevin ; et al. | 2013-07-18 |
| Immunogenic Compositions And Related Methods App 20130034579 - Harper; Kevin ; et al. | 2013-02-07 |
| Monoclonal antibodies and uses thereof Grant 8,361,706 - Berinstein , et al. January 29, 2 | 2013-01-29 |
| Tumor Antigens for the Prevention and/or Treatment of Cancer App 20130011422 - Berinstein; Neil ; et al. | 2013-01-10 |
| Monoclonal Antibodies and Uses Thereof App 20120295275 - Berinstein; Neil ; et al. | 2012-11-22 |
| Tumor antigens for prevention and/or treatment of cancer Grant 8,207,314 - Berinstein , et al. June 26, 2 | 2012-06-26 |
| Tumor Antigens BFA5 for Prevention and/or Treatment of Cancer App 20110311543 - Berinstein; Neil ; et al. | 2011-12-22 |
| Tumor antigens Bfa5 for prevention and/or treatment of cancer Grant 8,021,664 - Berinstein , et al. September 20, 2 | 2011-09-20 |
| Tumor Antigens Bfa4 And Bcy1 For Prevention And / Or Treatment Of Cancer App 20110117640 - Berinstein; Neil ; et al. | 2011-05-19 |
| Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer Grant 7,851,213 - Berinstein , et al. December 14, 2 | 2010-12-14 |
| Tumor Antigen Bfy3 For Prevention And/or Treatment Of Cancer App 20100278848 - Berinstein; Neil ; et al. | 2010-11-04 |
| Immunization Against Chlamydia Infection App 20080166376 - Brunham; Robert ; et al. | 2008-07-10 |
| Tumor Antigens Bfa5 For Prevention And/Or Treatment Of Cancer App 20080138365 - Berinstein; Neil ; et al. | 2008-06-12 |
| Immunization Against Chlamydia Infection App 20080019994 - Brunham; Robert ; et al. | 2008-01-24 |
| Tumor antigen BFA5 for prevention and / or treatment of cancer App 20050112099 - Berinstein, Neil ; et al. | 2005-05-26 |
| Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer App 20040197912 - Berinstein, Neil ; et al. | 2004-10-07 |
| Minimal adenovirus mediated recombinant vaccine App 20020088014 - Fang, Xiangming ; et al. | 2002-07-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 